FCN1 and acute myeloid leukemia: GSEA further demonstrated significant enrichment of FCN1 in various pathways implicated in AML pathogenesis, encompassing apoptosis regulation, cell proliferation, differentiation, and cell survival, alongside its involvement in immune response regulation and inflammation.